Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
McKinsey
Mallinckrodt
AstraZeneca
Baxter

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Pld Acquisitions Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for PLD ACQUISITIONS, and what generic and branded alternatives to PLD ACQUISITIONS drugs are available?

PLD ACQUISITIONS has eight approved drugs.



Summary for Pld Acquisitions
US Patents:0
Tradenames:8
Ingredients:8
NDAs:8

Drugs and US Patents for Pld Acquisitions

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pld Acquisitions Llc NAPROXEN SODIUM naproxen sodium TABLET;ORAL 074646-001 Jan 13, 1997 DISCN No No   Start Trial   Start Trial
Pld Acquisitions Llc ZOLMITRIPTAN zolmitriptan TABLET;ORAL 207867-001 Feb 27, 2017 AB RX No No   Start Trial   Start Trial
Pld Acquisitions NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 207868-001 Feb 7, 2019 OTC No No   Start Trial   Start Trial
Pld Acquisitions FAMOTIDINE famotidine TABLET;ORAL 075302-001 Apr 16, 2001 DISCN No No   Start Trial   Start Trial
Pld Acquisitions CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET;ORAL 077946-001 Dec 27, 2007 OTC No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Merck
Harvard Business School
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.